Literature DB >> 6135438

Concentration-effect relationships with FM 24: a new long acting beta-adrenergic receptor antagonist.

C T Dollery, H J Dargie, J Sassard, G Cuisinaud.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6135438      PMCID: PMC1427922          DOI: 10.1111/j.1365-2125.1983.tb01554.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  18 in total

1.  Plasma concentrations and the time-course of beta blockade due to propranolol.

Authors:  D G McDevitt; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-12       Impact factor: 6.875

2.  Can chloropractolol alkylate beta adrenoceptors?

Authors:  T P Kenakin; J W Black
Journal:  Nature       Date:  1977-01-27       Impact factor: 49.962

3.  Correlation of plasma propranolol concentration with therapeutic response in patients with angina pectoris.

Authors:  M Pine; L Favrot; S Smith; K McDonald; C A Chidsey
Journal:  Circulation       Date:  1975-11       Impact factor: 29.690

4.  Muscle activity decreases rate of degradation of alpha-bungarotoxin bound to extrajunctional acetylcholine receptors.

Authors:  P G Hogan; J M Marshall; Z W Hall
Journal:  Nature       Date:  1976-05-27       Impact factor: 49.962

5.  Potential probe for isolation of the beta-adrenoceptor, chloropractolol.

Authors:  M Erez; M Weinstock; S Cohen; G Shtacher
Journal:  Nature       Date:  1975-06-19       Impact factor: 49.962

6.  Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression.

Authors:  R J Lee; D B Evans; S H Baky; R J Laffan
Journal:  Eur J Pharmacol       Date:  1975 Sep-Oct       Impact factor: 4.432

7.  Plasma binding and the affinity of propranolol for a beta receptor in man.

Authors:  D G McDevitt; M Frisk-Holmberg; J W Hollifield; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1976-08       Impact factor: 6.875

8.  Drug concentrations in the plasma as an index of pharmacologic effect.

Authors:  D Perrier; M Gibaldi
Journal:  J Clin Pharmacol       Date:  1974 Aug-Sep       Impact factor: 3.126

9.  Relation of propranolol plasma level to beta-blockade during oral therapy.

Authors:  R Zacest; J Koch-Weser
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

10.  Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.

Authors:  D J Coltart; D G Shand
Journal:  Br Med J       Date:  1970-09-26
View more
  2 in total

1.  Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

2.  Beta-adrenoceptor blocking effects and plasma levels of bornaprolol and propranolol in man.

Authors:  C Thuillez; C Richer; P Duhazé; L Bergougnan; J F Giudicelli
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.